Home
INI CET
Pharmacology

Filters

Found 1 Question

Set Default

Exams

INI CET

Years

2026

Subjects

Pharmacology

Topics

Novel antidepressants - vilazodone
Anti-ageing drugs and molecular targets
Antiplatelet drugs - ticagrelor (P2Y12 inhibitor)
Beta thalassemia major pathophysiology
Cardiac involvement in systemic sclerosis (myocardial fibrosis)
Fenfluramine adverse effects and monitoring
GPCR signalling - G-protein coupling of receptors
Geriatrics - frailty and sarcopenia
Geriatrics - risk factors for falls in the elderly
Histology special stains - liver fibrosis
Lithium toxicity - NSAID interaction
Microcytic anemia diagnosis (iron deficiency)
Migraine prophylaxis - drug choice
Mushroom poisoning - muscarinic toxicity
Receptor types / ligand-gated ion channels
Renin secretion control (RAAS)
SIADH - vaptan therapy
Smoking cessation - nicotine replacement therapy
Strongyloidiasis - drug of choice
Targeted anticancer therapy - tyrosine kinase inhibitors
Therapeutic index from quantal dose-response curve
Vasculitis classification by vessel size
Wilson disease and copper chelation therapy

List of top Pharmacology Questions on Novel antidepressants - vilazodone asked in INI CET

Which of the following is a novel antidepressant?

INI CET - 2026
INI CET
Pharmacology
Novel antidepressants - vilazodone

terms & conditions

Privacy & Policy

© 2026 Patronum Web Private Limited